---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-26T23:01:05.473770'
end_time: '2025-12-26T23:06:22.159201'
duration_seconds: 316.69
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: AP4B1
  gene_symbol: AP4B1
  uniprot_accession: Q9Y6B7
  protein_description: 'RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName:
    Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein
    complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;'
  gene_info: Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the adaptor complexes large subunit family.
  protein_domains: AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like.
    (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 19
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9Y6B7
- **Protein Description:** RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;
- **Gene Information:** Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the adaptor complexes large subunit family.
- **Key Domains:** AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "AP4B1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **AP4B1** (gene ID: AP4B1, UniProt: Q9Y6B7) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9Y6B7
- **Protein Description:** RecName: Full=AP-4 complex subunit beta-1 {ECO:0000305}; AltName: Full=AP-4 adaptor complex subunit beta; AltName: Full=Adaptor-related protein complex 4 subunit beta-1; AltName: Full=Beta subunit of AP-4; AltName: Full=Beta4-adaptin;
- **Gene Information:** Name=AP4B1 {ECO:0000312|HGNC:HGNC:572};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the adaptor complexes large subunit family.
- **Key Domains:** AP_beta. (IPR026739); AP_complex_bsu_1_2_4. (IPR016342); ARM-like. (IPR011989); ARM-type_fold. (IPR016024); B-adaptin_app_sub_C. (IPR015151)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "AP4B1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'AP4B1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **AP4B1** (gene ID: AP4B1, UniProt: Q9Y6B7) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan status. Objective 1 (identity verification) completed. Objectives 2–6 addressed through curated literature and database evidence; final report submitted below with citations.

Comprehensive research report: AP4B1 (UniProt: Q9Y6B7) – AP-4 complex subunit beta-1

Key concepts and definitions
- Identity and complex membership: AP4B1 encodes the beta-1 (β4) subunit of the heterotetrameric adaptor protein complex 4 (AP-4), together with AP4E1 (ε), AP4M1 (μ4), and AP4S1 (σ4). AP-4 functions as a non-clathrin coat at the trans-Golgi network (TGN) that selects transmembrane cargos into vesicles for post-Golgi trafficking; μ4 binds YXXØ-like signals, and the complex interacts with Arf1-GTP. AP-4 recruitment also engages the accessory protein tepsin (AP4AT/ENTHD2). AP4B1 corresponds to β4-adaptin, a large subunit with AP_beta/ARM-like domains, consistent with the adaptor complexes large subunit family (Homo sapiens). (mattera2017ap4mediatesexport pages 1-2)
- Primary molecular role: AP-4 mediates signal-dependent export of selected cargos—most prominently ATG9A—from the TGN to endosomal/peripheral compartments that support autophagosome formation. Loss of AP-4 causes ATG9A retention in the TGN and alters LC3B lipidation readouts, linking AP-4 to autophagy pathways. (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2)

Subcellular localization and trafficking route
- Localization: AP-4 localizes to the TGN (perinuclear), forms AP-4–derived vesicles, and facilitates cargo delivery to early/late endosomes and pre-autophagosomal structures (PAS). In neurons, AP-4–dependent carriers support axonal/peripheral distribution of ATG9A critical for autophagy. (ivankovic2020axonalautophagosomematuration pages 1-3, mattera2017ap4mediatesexport pages 1-2)
- Route and machinery: AP-4 drives TGN export of ATG9A to endosomal/PAS compartments. RUSC-family proteins mediate peripheral delivery of AP-4 vesicles containing ATG9A, positioning an “ATG9A reservoir” near autophagosome biogenesis sites. The FTS–Hook–FHIP (FHF) complex binds AP-4 and dynein–dynactin to maintain perinuclear AP-4/ATG9A distribution, revealing coat–motor coupling in AP-4 traffic. (ivankovic2020axonalautophagosomematuration pages 1-3, mattera2017ap4mediatesexport pages 1-2)

Known cargos and interacting partners
- Cargos: ATG9A is a validated AP-4 cargo across multiple systems; missorting is a hallmark of AP-4 loss. Additional AP-4–dependent localization changes were reported for SERINC1/3 in proteomic mapping studies. (behne2020adaptorproteincomplex pages 1-2)
- Accessory factors and interactors: Tepsin associates with AP-4 but is not required for ATG9A export from the TGN in HeLa/MEFs; AP-4 interacts with Arf1-GTP, and μ4 binds canonical cargo motifs. FHF (Hook1/2–FHIP) interacts with AP-4 μ4 to control perinuclear positioning; RUSC proteins facilitate peripheral delivery of AP-4 vesicles; recent data implicate SCAMP5 in neuronal AP-4 localization and ATG9A presynaptic delivery. (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3, ryu2023scamp5ap4dependenttrafficking pages 23-34)

Recent developments and latest research (2023–2024 priority)
- SCAMP5–AP-4 axis in neurons (2023): SCAMP5 co-immunoprecipitates with AP-4 (AP4M1) and supports AP-4 localization at the TGN. SCAMP5 knockdown reduces AP4M1 intensity and AP-4/TGN38 colocalization, decreases ATG9A axonal puncta density (~9.37 ± 0.40 to 4.74 ± 0.36 puncta per 50 μm; rescue to 9.96 ± 0.47), and lowers the fraction of presynaptic LC3-positive boutons under activity induction (71.7% ± 4.7% to 35.0% ± 9.0%), linking SCAMP5 to AP-4–dependent presynaptic autophagy. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)
- Coat–motor coupling: The AP-4–FHF (Hook1/Hook2–FHIP) interaction, reported earlier, clarifies how AP-4 vesicles are positioned perinuclearly via dynein–dynactin and complements RUSC-dependent peripheral transport of ATG9A carriers. This mechanistic framework underlies spatial control of autophagy via ATG9A supply. Molecular Biology of the Cell; Apr 2020; https://doi.org/10.1091/mbc.e19-11-0658; Nature Communications; Sep 2018; https://doi.org/10.1038/s41467-018-06172-7. (ivankovic2020axonalautophagosomematuration pages 1-3)
- Diagnostic/therapeutic direction of travel: High-content imaging of ATG9A redistribution is being developed as a functional assay in AP-4 deficiency models; emerging screening efforts aim to identify modulators that normalize ATG9A trafficking in AP-4 deficiency. bioRxiv (Feb 2025) highlights a neuronal CRISPR screen mapping ATG9A trafficking regulators, indicating a growing target space; while beyond 2024, it underscores momentum in therapeutic hypothesis generation. https://doi.org/10.1101/2025.02.22.639634. (ziegler2025arrayedcrisprcas9lossoffunction pages 53-56)

Current applications and real-world implementations
- Diagnostic biomarkers in patient cells: In AP-4–deficient patient fibroblasts (including AP4B1), ATG9A accumulates in the TGN and total ATG9A increases 3–5-fold. Re-expression of AP4B1 restores ATG9A distribution. These quantitative changes support a robust cell-based biomarker and functional readout for variant interpretation. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)
- Neuronal models for pathomechanism: Patient iPSC-derived cortical neurons show reduced LC3-II and impaired neurite outgrowth/branching, aligning with neurodevelopmental features of AP-4 deficiency and providing preclinical platforms for screening and mechanistic studies. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)

Expert opinions and analysis from authoritative sources
- AP-4 as a TGN export adaptor for autophagy machinery: Core primary papers converge on AP-4’s role in cargo-selective export from the TGN, with ATG9A being the principal cargo linked to autophagosome biogenesis. The neuron-selective consequences of ATG9A mislocalization—axonal depletion, autophagosome maturation defects, and axonal swellings—provide a parsimonious mechanistic basis for AP-4 deficiency neuropathology. PNAS; Nov 2017; https://doi.org/10.1073/pnas.1717327114; Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302. (mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3)
- Spatial control of ATG9A supply: Complementary studies define perinuclear retention (FHF–dynein) versus peripheral delivery (RUSC) of AP-4/ATG9A vesicles, framing AP-4 as a gatekeeper of ATG9A spatial availability. Perturbations in this axis plausibly compromise distal axonal autophagy and synaptic health. Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302. (ivankovic2020axonalautophagosomematuration pages 1-3)
- Emerging neuronal modulators: New neuronal data (SCAMP5) refine the adaptor landscape governing AP-4 localization and presynaptic ATG9A, highlighting additional entry points for therapeutic modulation. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)

Relevant statistics and quantitative data
- Disease association: Open Targets lists AP4B1 associated with “genetic disorder” (score ~0.816), “Severe intellectual disability and progressive spastic paraplegia” (score ~0.767), “Spastic paraplegia” (score ~0.753), “AP-4 deficiency syndrome” (score ~0.372), and “spastic quadriplegic cerebral palsy” (score ~0.370); evidence includes multiple literature PMIDs and clinical resources, with biallelic autosomal inheritance noted. Nucleic Acids Research (platform reference); accessed via Open Targets query. (OpenTargets Search: -AP4B1)
- Cellular biomarker magnitude: Patient fibroblasts show 3–5× increased ATG9A protein and juxtanuclear/TGN retention; AP-4 re-expression normalizes distribution. Human Molecular Genetics; Jan 2020; https://doi.org/10.1093/hmg/ddz310. (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)
- Neuronal trafficking and autophagy metrics (2023): SCAMP5 knockdown reduces axonal ATG9A puncta (~9.37 → 4.74 per 50 μm) and activity-induced LC3-positive boutons (~71.7% → 35.0%), quantifying presynaptic autophagy dependence on SCAMP5–AP-4–ATG9A trafficking. IBRO Neuroscience Reports; Oct 2023; https://doi.org/10.1016/j.ibneur.2023.08.624. (ryu2023scamp5ap4dependenttrafficking pages 23-34)

Mechanistic link to disease (AP-4 deficiency syndrome; SPG47 for AP4B1)
- Genetics and clinical phenotype: Biallelic loss-of-function variants in AP4B1 cause a complicated hereditary spastic paraplegia (AP-4 deficiency syndrome, SPG47) with severe intellectual disability, progressive spasticity, absent/limited speech, thin corpus callosum, ventriculomegaly, seizures, and growth delay. (mattera2017ap4mediatesexport pages 1-2, ivankovic2020axonalautophagosomematuration pages 1-3)
- Cellular pathogenesis: AP-4 loss retains ATG9A at the TGN, depletes axonal ATG9A, and impairs autophagosome biogenesis/maturation in axons, leading to distal axonal swellings enriched in ER and impaired axonal extension/integrity. (Autophagy; May 2020; https://doi.org/10.1080/15548627.2019.1615302). (ivankovic2020axonalautophagosomematuration pages 1-3)
- Organismal models: AP-4 epsilon knockout mice recapitulate neuroanatomical phenotypes and axonal pathology consistent with human disease, supporting causality from AP-4–ATG9A trafficking defects to motor system dysfunction. (ivankovic2020axonalautophagosomematuration pages 1-3)

Evidence synthesis: AP4B1 encodes β4-adaptin, an obligate AP-4 subunit that forms a non-clathrin TGN coat to select cargos including ATG9A for export. Accessory and motor-coupling factors (tepsin, FHF, RUSC) and neuronal modulators (SCAMP5) orchestrate perinuclear retention and peripheral/axonal delivery of AP-4 vesicles. In AP-4 deficiency, ATG9A missorting explains neuron-selective autophagy defects and axonopathy. Quantitative cellular markers (ATG9A TGN retention and overexpression) and neuronal phenotypes (reduced LC3-II, impaired neuritogenesis; reduced presynaptic autophagy) provide actionable readouts for diagnostics and therapeutic screening. (mattera2017ap4mediatesexport pages 9-9, ivankovic2020axonalautophagosomematuration pages 1-3, behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10, mattera2017ap4mediatesexport pages 1-2, ryu2023scamp5ap4dependenttrafficking pages 23-34, OpenTargets Search: -AP4B1)

Insertable summary artifact
| Category | Key point | Evidence / quantitative detail | Primary sources (DOI URL, publication date) |
|---|---|---:|---|
| Identity | Human AP4B1 = beta-1 (β4) adaptin; large subunit of AP-4; contains AP_beta and ARM-like domains | UniProt Q9Y6B7 identity and literature consistency with β4-adaptin annotation | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |
| Complex composition | AP-4 is an obligate heterotetramer: AP4E1 (ε), AP4B1 (β), AP4M1 (μ), AP4S1 (σ) | Described as obligate heterotetrameric coat complex in cellular studies | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |
| Molecular function | Cargo selection for TGN-derived vesicles; μ4 recognizes YXXØ-like signals; forms a non-clathrin coat at the TGN to sort transmembrane cargos | AP-4 promotes signal-mediated export of cargos (notably ATG9A) from TGN; loss alters LC3B lipidation under some conditions | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |
| Subcellular localization | AP-4 localizes to the trans‑Golgi network (TGN), perinuclear region and AP-4–derived vesicles that travel to peripheral/axonal sites | TGN-associated coat and perinuclear distribution; peripheral/axonal delivery documented in neuronal models | Ivankovic et al., Autophagy; https://doi.org/10.1080/15548627.2019.1615302 (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Behne et al., Hum Mol Genet (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |
| Trafficking route | TGN → early/late endosomes → pre‑autophagosomal structures (PAS) and peripheral/axonal sites; RUSC1/2 mediate peripheral delivery | AP-4–dependent export of ATG9A from TGN to endosomal/PAS compartments; RUSC-dependent peripheral transport of ATG9A vesicles | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Behne et al., Hum Mol Genet (Jan 2020) (behne2020adaptorproteincomplex pages 1-2) |
| Cargos | Validated cargos include ATG9A (primary) and reported AP-4–dependent localization changes for SERINC1/3 | ATG9A is consistently identified as a major AP-4 cargo across cell and neuronal models | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Mattera et al., PNAS (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |
| Accessory / interactors | Tepsin (ENTHD2/AP4AT), FHF complex (Hook1/2, FHIP), Arf1, RUSC1/2, SCAMP5 (neuronal) | Protein–protein interaction and functional assays show recruitment/coordination for AP-4 vesicle formation and positioning | Mattera et al., PNAS; https://doi.org/10.1073/pnas.1717327114 (Nov 2017) (mattera2017ap4mediatesexport pages 1-2), Mattera et al., Mol Biol Cell (FHF) (2020) summarized in reviews and Behne et al. (behne2020adaptorproteincomplex pages 1-2), Ryu et al., IBRO Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34) |
| 2023–2024 updates | SCAMP5 required for presynaptic AP‑4 localization and ATG9A delivery; tepsin–LC3B link promotes ATG9A export to periphery (recent mechanistic modifiers) | Ryu 2023: SCAMP5 KD reduces axonal ATG9A puncta (~9.37 → 4.74 puncta/50 μm) and lowers % LC3+ boutons (71.7% → 35.0%); tepsin–LC3B studies reported 2023 bioRxiv (mechanistic accessory role) | Ryu et al., IBRO Neurosci Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34), Mattera et al./related tepsin data (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2) |
| Disease | AP‑4 deficiency syndrome (SPG47 for AP4B1): autosomal recessive, severe early‑onset neurodevelopmental disorder with spasticity, intellectual disability, absent/limited speech, thin corpus callosum | OpenTargets association scores high for genetic disorder / spastic paraplegia; allelic requirement = biallelic autosomal (reported literature) | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), OpenTargets summary (disease associations) (OpenTargets Search: -AP4B1) |
| Cellular phenotypes (patients/models) | ATG9A retention at TGN; 3–5× increased ATG9A levels in patient fibroblasts; reduced LC3‑II in iPSC‑neurons; impaired neurite outgrowth/branching | Quantified: 3–5× ATG9A upregulation in patient fibroblasts; decreased LC3-II/LC3-I ratio in patient iPSC‑neurons; large-scale neurite assays (>90k neurons) show reduced branching | Behne et al., Hum Mol Genet; https://doi.org/10.1093/hmg/ddz310 (Jan 2020) (behne2020adaptorproteincomplex pages 1-2), Ivankovic et al., Autophagy (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Mattera et al., PNAS (Nov 2017) (mattera2017ap4mediatesexport pages 1-2) |
| Organismal phenotypes (models) | Ap4e1 KO mice recapitulate axonal defects: distal axonal swellings, impaired axonal extension and thin corpus callosum-like features | Mouse KO shows axonal autophagy/extension defects and neuroanatomical phenotypes consistent with human disease | Ivankovic et al., Autophagy; https://doi.org/10.1080/15548627.2019.1615302 (May 2020) (ivankovic2020axonalautophagosomematuration pages 1-3), Behne et al., Hum Mol Genet (behne2020adaptorproteincomplex pages 1-2) |
| Diagnostics / therapeutics | High-throughput imaging of ATG9A distribution proposed as functional diagnostic assay; preliminary screens/efforts to find modulators that restore trafficking reported in recent work | Functional ATG9A redistribution assay used in labs/patient-derived cells; preliminary screen reports and preclinical modulators referenced in recent datasets | Ebrahimi‑Fakhari / group assay reports summarized in reviews and screening efforts (ziegler2025arrayedcrisprcas9lossoffunction pages 53-56, behne2020adaptorproteincomplex pages 1-2), OpenTargets disease-context (OpenTargets Search: -AP4B1) |
| Statistics / quantitative metrics | OpenTargets association scores: "genetic disorder" ~0.816, "Severe intellectual disability and progressive spastic paraplegia" ~0.767; Ryu 2023 imaging metrics (puncta and % LC3+ boutons as above) | Quantitative association scores and imaging readouts provide diagnostic/experimental benchmarks | OpenTargets platform (disease scores) (OpenTargets Search: -AP4B1), Ryu et al., IBRO Rep; https://doi.org/10.1016/j.ibneur.2023.08.624 (Oct 2023) (ryu2023scamp5ap4dependenttrafficking pages 23-34) |


*Table: Compact summary table of AP4B1 (UniProt Q9Y6B7) and AP‑4 complex: functions, localization, cargos, interactors, disease links, key quantitative findings and primary literature (context IDs cited). Useful as a quick reference linking mechanistic points to core sources.*

Key source list with URLs and dates
- Mattera et al., PNAS 2017. AP-4 mediates export of ATG9A from the TGN; AP4B1 is β4-adaptin; tepsin is not required for ATG9A export in tested cells. https://doi.org/10.1073/pnas.1717327114 (Published Nov 2017). (mattera2017ap4mediatesexport pages 9-9, mattera2017ap4mediatesexport pages 1-2)
- Ivankovic et al., Autophagy 2020. Failure of ATG9A sorting underpins axonal autophagosome maturation defects and axonopathy in AP-4 deficiency; model recapitulates neuroanatomy. https://doi.org/10.1080/15548627.2019.1615302 (Published May 2020). (ivankovic2020axonalautophagosomematuration pages 1-3)
- Behne et al., Human Molecular Genetics 2020. Patient fibroblasts and iPSC neurons show ATG9A TGN retention, 3–5× ATG9A upregulation, reduced LC3-II in neurons, impaired neuritogenesis; AP4B1 re-expression rescues ATG9A distribution. https://doi.org/10.1093/hmg/ddz310 (Advance Access Jan 9, 2020). (behne2020adaptorproteincomplex pages 1-2, behne2020adaptorproteincomplex pages 6-10)
- Ryu et al., IBRO Neuroscience Reports 2023. SCAMP5–AP-4 interaction supports TGN localization and presynaptic delivery of ATG9A; quantitative deficits in axonal puncta and LC3-positive boutons upon SCAMP5 knockdown. https://doi.org/10.1016/j.ibneur.2023.08.624 (Published Oct 2023). (ryu2023scamp5ap4dependenttrafficking pages 23-34)
- Open Targets Platform (accessed 2025; platform citation NAR). Quantitative disease association scores linking AP4B1 to spastic paraplegia spectrum and AP-4 deficiency syndrome; biallelic inheritance. (Open Targets query for AP4B1). (OpenTargets Search: -AP4B1)

Notes on gene/protein identification and domain/family consistency
- The gene symbol AP4B1 (HGNC:572) and UniProt Q9Y6B7 match the human AP-4 β subunit (β4-adaptin) with large-subunit adaptor domains (AP_beta; ARM-like), fully consistent with adaptor complex architecture reported in primary studies. No conflicting gene symbol usage was found in other organisms in the cited literature. (mattera2017ap4mediatesexport pages 1-2)


References

1. (mattera2017ap4mediatesexport pages 1-2): Rafael Mattera, Sang Yoon Park, Raffaella De Pace, Carlos M. Guardia, and Juan S. Bonifacino. Ap-4 mediates export of atg9a from the trans-golgi network to promote autophagosome formation. Proceedings of the National Academy of Sciences, 114:E10697-E10706, Nov 2017. URL: https://doi.org/10.1073/pnas.1717327114, doi:10.1073/pnas.1717327114. This article has 182 citations and is from a highest quality peer-reviewed journal.

2. (mattera2017ap4mediatesexport pages 9-9): Rafael Mattera, Sang Yoon Park, Raffaella De Pace, Carlos M. Guardia, and Juan S. Bonifacino. Ap-4 mediates export of atg9a from the trans-golgi network to promote autophagosome formation. Proceedings of the National Academy of Sciences, 114:E10697-E10706, Nov 2017. URL: https://doi.org/10.1073/pnas.1717327114, doi:10.1073/pnas.1717327114. This article has 182 citations and is from a highest quality peer-reviewed journal.

3. (ivankovic2020axonalautophagosomematuration pages 1-3): Davor Ivankovic, James Drew, Flavie Lesept, Ian J. White, Guillermo López Doménech, Sharon A. Tooze, and Josef T. Kittler. Axonal autophagosome maturation defect through failure of atg9a sorting underpins pathology in ap-4 deficiency syndrome. Autophagy, 16:391-407, May 2020. URL: https://doi.org/10.1080/15548627.2019.1615302, doi:10.1080/15548627.2019.1615302. This article has 85 citations and is from a domain leading peer-reviewed journal.

4. (behne2020adaptorproteincomplex pages 1-2): Robert Behne, Julian Teinert, Miriam Wimmer, Angelica D’Amore, Alexandra K Davies, Joseph M Scarrott, Kathrin Eberhardt, Barbara Brechmann, Ivy Pin-Fang Chen, Elizabeth D Buttermore, Lee Barrett, Sean Dwyer, Teresa Chen, Jennifer Hirst, Antje Wiesener, Devorah Segal, Andrea Martinuzzi, Sofia T Duarte, James T Bennett, Thomas Bourinaris, Henry Houlden, Agathe Roubertie, Filippo M Santorelli, Margaret Robinson, Mimoun Azzouz, Jonathan O Lipton, Georg H H Borner, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Human molecular genetics, 29:320-334, Jan 2020. URL: https://doi.org/10.1093/hmg/ddz310, doi:10.1093/hmg/ddz310. This article has 79 citations and is from a domain leading peer-reviewed journal.

5. (ryu2023scamp5ap4dependenttrafficking pages 23-34): Seung Hyun Ryu, Jungmihn Lee, Unghwi Lee, Kitae Kim, and Sunghoe Chang. Scamp5/ap-4 dependent trafficking mediates presynaptic localization of the core autophagy protein atg9a. IBRO Neuroscience Reports, Oct 2023. URL: https://doi.org/10.1016/j.ibneur.2023.08.624, doi:10.1016/j.ibneur.2023.08.624. This article has 0 citations and is from a peer-reviewed journal.

6. (ziegler2025arrayedcrisprcas9lossoffunction pages 53-56): Marvin Ziegler, Cedric Böger, Julian E. Alecu, Hyo-Min Kim, Afshin Saffari, Alexandra K. Davies, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Arrayed crispr/cas9 loss-of-function screen in a neuronal model of adaptor protein complex 4 deficiency identifies modulators of atg9a trafficking. bioRxiv, Feb 2025. URL: https://doi.org/10.1101/2025.02.22.639634, doi:10.1101/2025.02.22.639634. This article has 0 citations and is from a poor quality or predatory journal.

7. (behne2020adaptorproteincomplex pages 6-10): Robert Behne, Julian Teinert, Miriam Wimmer, Angelica D’Amore, Alexandra K Davies, Joseph M Scarrott, Kathrin Eberhardt, Barbara Brechmann, Ivy Pin-Fang Chen, Elizabeth D Buttermore, Lee Barrett, Sean Dwyer, Teresa Chen, Jennifer Hirst, Antje Wiesener, Devorah Segal, Andrea Martinuzzi, Sofia T Duarte, James T Bennett, Thomas Bourinaris, Henry Houlden, Agathe Roubertie, Filippo M Santorelli, Margaret Robinson, Mimoun Azzouz, Jonathan O Lipton, Georg H H Borner, Mustafa Sahin, and Darius Ebrahimi-Fakhari. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking. Human molecular genetics, 29:320-334, Jan 2020. URL: https://doi.org/10.1093/hmg/ddz310, doi:10.1093/hmg/ddz310. This article has 79 citations and is from a domain leading peer-reviewed journal.

8. (OpenTargets Search: -AP4B1): Open Targets Query (-AP4B1, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

## Citations

1. behne2020adaptorproteincomplex pages 1-2
2. ivankovic2020axonalautophagosomematuration pages 1-3
3. behne2020adaptorproteincomplex pages 6-10
4. https://doi.org/10.1016/j.ibneur.2023.08.624.
5. https://doi.org/10.1091/mbc.e19-11-0658;
6. https://doi.org/10.1038/s41467-018-06172-7.
7. https://doi.org/10.1101/2025.02.22.639634.
8. https://doi.org/10.1093/hmg/ddz310.
9. https://doi.org/10.1073/pnas.1717327114;
10. https://doi.org/10.1080/15548627.2019.1615302.
11. https://doi.org/10.1080/15548627.2019.1615302
12. https://doi.org/10.1073/pnas.1717327114
13. https://doi.org/10.1093/hmg/ddz310
14. https://doi.org/10.1016/j.ibneur.2023.08.624
15. https://doi.org/10.1073/pnas.1717327114,
16. https://doi.org/10.1080/15548627.2019.1615302,
17. https://doi.org/10.1093/hmg/ddz310,
18. https://doi.org/10.1016/j.ibneur.2023.08.624,
19. https://doi.org/10.1101/2025.02.22.639634,